STUDY COMPARING TWO ALTERNATIVES OF ANTIRETROVIRAL THERAPY AS POST-EXPOSURE PROPHYLAXIS TO HIV-1: TENOFOVIR + EMTRICITABINE + LOPINAVIR/RITONAVIR VERSUS TENOFOVIR + EMTRICITABINE + RALTEGRAVIR (RAL-PEP):